Delivery Order SPE2DB20D7061-SPE2DB25FSPE9
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,361.72 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $187,438.32 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed-price contract, which has no set-aside designation, is scheduled for completion by July 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.99 million...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $34,875.00 by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded non-set-aside procurement. The award is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,140.76 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract is a firm fixed price delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which holds a prime contract ceiling of $999,999,999.00 running through December 2026. This delivery order was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,243.74 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $31,793.84 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $39,550.98 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The delivery order is scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,324.37 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price delivery order, which was not set-aside and competitively awarded, is scheduled for completion by August 12, 2025, with performance at the company's Conshohocken location. The award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $146,237.40 by the Defense Logistics Agency's Medical Supply Chain division under a firm fixed-price contract. The delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) SPE2DX valued at $999,999,999.00 through December 2026. This award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $19,091.88 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, which utilized no set-aside designation, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPE9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $21,288.34 by the Defense Logistics Agency for Abrysvo vial with diluent syringes. This firm fixed price contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement. The order will be fulfilled at AmerisourceBergen's Conshohocken facility and is expected to support federal medical supply requirements, likely for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, medical devices, and related healthcare commodities across multiple therapeutic domains. The current delivery order for Abrysvo demonstrates the company's continued role as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, supporting the broader military healthcare procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 8/11/25 |